معرفی
Prof. Wim Tissing is a Professor at the University of Groningen's Faculty of Medical Sciences, affiliated with the Innovative Clinical Studies and Long-term Treatment Consequences in Cancer (InClinS) research group. His work focuses on pediatric oncology, particularly childhood cancer survivors' long-term health outcomes, treatment-related complications, and clinical trial design.
Research interests include childhood cancer (e.g., acute lymphoblastic leukemia), metabolic syndrome in cancer survivors, immunological interventions, and quality-of-life improvements for pediatric patients. He leads studies on infection prevention, stem cell mobilization, and nutritional management in oncology.
Recent articles highlight advancements in fever prevention via immunoglobulin prophylaxis, stem cell transplantation optimization, and dietary strategies for taste/smell disorders in cancer care. His work contributes to UN Sustainable Development Goals related to health and well-being.
Prof. Tissing has supervised over 10 research projects, co-created clinical guidelines, and contributed datasets on methotrexate-induced mucositis. Media coverage includes studies on obesity trends in childhood cancer survivors.
